MB 1
BULLETS
Free CME
Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 106477

Neonatal Respiratory Distress Syndrome Evaluation Treatment Prevention  corticosteroids given to mother between 23 and 34 weeks gestation at increased risk for preterm delivery within 7 days   results in increased surfactant production  Treatment nasal CPAP QID: 106477 (M1.PL.14.70)
In scope icon M 3 E
QID 106477 (Type "106477" in App Search)
A G1P0 diabetic woman is at risk of delivering at 30 weeks gestation. Her obstetrician counsels her that there is a risk the baby could have significant pulmonary distress after it is born. However, she states she will administer a drug to the mother to help prevent this from occurring. By what action will this drug prevent respiratory distress in the premature infant?
Type in at least one full word to see suggestions list